Borderline Personality Disorder Clinical Trial
— M-GABOfficial title:
Mentalization-Based Treatment in Groups for Adolescents With Borderline Personality Disorder (BPD) or Subthreshold BPD Versus Treatment As Usual - the M-GAB Randomized Controlled Trial
NCT number | NCT02068326 |
Other study ID # | SJ-371 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2015 |
Est. completion date | April 11, 2019 |
Verified date | June 2020 |
Source | Psychiatric Research Unit, Region Zealand, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Although it is now possible to diagnose Borderline Personality Disorder (BPD) in
adolescents younger than 18 years according to the Diagnostic and Statistical Manual of
Mental Disorders, 5th edition (DSM-V), and studies indicates that BPD can be reliably
diagnosed in adolescence, only a few evidence based treatment programmes for adolescent BPD
exists. Mentalization-based treatment (MBT), including group psychotherapy, has repeatedly
shown to be effective in treating adult BPD, but in the case of adolescents, only individual
MBT have been tested and found to be effective.
Aims/hypotheses: We will test whether group based MBT (MBT-G), including an introductory
programme for patients (MBT-I) and their parents (MBT-P) is more effective than Treatment As
Usual (TAU) in treating adolescents with BPD or subthreshold BPD.
Methods/Design: 112 patients referred to child and adolescent psychiatric clinics in Region
Zealand will be randomized to either MBT or TAU. Inclusion criteria: Meeting DSM-V
BPD-criteria at the threshold (five criteria) or sub threshold level (4 criteria). Follow-up
will be at three and 12 months.
Discussion: Early intervention is especially important in relation to personality
psychopathology and has long-term benefits for patients, their families and society. In
addition to being cost effective, using the group modality in the treatment of BPD may have
several advantages. This is the first Randomized Controlled Trial (RCT) to test the
effectiveness of MBT in groups for adolescents.
Status | Completed |
Enrollment | 112 |
Est. completion date | April 11, 2019 |
Est. primary completion date | May 11, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Meet a minimum of 4 DSM-5 BPD criteria - Have parent's or parent substitute's commitment and ability to participate in the MBT-Parents program. - Score 67< BPFS-C Exclusion Criteria: - Comorbid diagnosis of pervasive developmental disorder, learning disability (75 < IQ), anorexia, current psychosis, diagnosis of schizophrenia or schizotypal personality disorder, antisocial personality disorder as well as any other axis-I or axis-II psychopathology considered to be the primary diagnosis. - Current psychiatric inpatient treatment - Current (past two months) substance dependence (but not substance misuse) - Participation in concurrent psychotherapeutic treatment outside the MBT program - Not able to speak Danish - Lack of informed consent |
Country | Name | City | State |
---|---|---|---|
Denmark | Child and Adolescent Psychiatric Department, Region Zealand | Roskilde | Region Zealand |
Lead Sponsor | Collaborator |
---|---|
Psychiatric Research Unit, Region Zealand, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Experience of Close Relationships Inventory (ECR) | Treatment related variable (mediator) | Change from baseline at 40 weeks | |
Other | Experience of Close Relationships Inventory (ECR) | Treatment related variable (mediator) | Change from baseline at 10 weeks | |
Other | Experience of Close Relationships Inventory (ECR) | Treatment related variable (mediator) | Change from baseline at 20 weeks | |
Other | Experience of Close Relationships Inventory (ECR) | Treatment related variable (mediator) | Change from baseline at 30 weeks | |
Other | Inventory of Parent and Peer Attachment - Revised (IPPA-R) | Treatment related variable (mediator) | Change from baseline at 40 weeks | |
Other | Inventory of Parent and Peer Attachment - Revised (IPPA-R) | Treatment related variable (mediator) | Change from baseline at 10 weeks | |
Other | Inventory of Parent and Peer Attachment - Revised (IPPA-R) | Treatment related variable (mediator) | Change from baseline at 20 weeks | |
Other | Inventory of Parent and Peer Attachment - Revised (IPPA-R) | Treatment related variable (mediator) | Change from baseline at 30 weeks | |
Other | Reflective Function Questionnaire for Youth (RFQ-Y) | Treatment related variable (mediator) | Change from baseline at 40 weeks | |
Other | Reflective Function Questionnaire for Youth (RFQ-Y) | Treatment related variable (mediator) | Change from baseline at 10 weeks | |
Other | Reflective Function Questionnaire for Youth (RFQ-Y) | Treatment related variable (mediator) | Change from baseline 20 weeks | |
Other | Reflective Function Questionnaire for Youth (RFQ-Y) | Treatment related variable (mediator) | Change from baseline at 30 weeks | |
Primary | The Borderline Personality Feature Scale for Children (BPFS-C) | Change from Baseline in BPFS-C at 40 weeks | ||
Primary | The Borderline Personality Feature Scale for Children (BPFS-C) | Change from Baseline in BPFS-C at 10 weeks | ||
Primary | The Borderline Personality Feature Scale for Children (BPFS-C) | Change from baseline at 20 weeks | ||
Primary | The Borderline Personality Feature Scale for Children (BPFS-C) | Change from baseline at 30 weeks | ||
Secondary | Becks Depression Inventory for Youth | Change from Baseline in at 10 weeks | ||
Secondary | Becks Depression Inventory for Youth | Change from Baseline in at 20 weeks | ||
Secondary | Becks Depression Inventory for Youth | Change from Baseline in at 30 weeks | ||
Secondary | Becks Depression Inventory for Youth | Change from Baseline in at 40 weeks | ||
Secondary | The Risk-Taking and Self-Harm Inventory for adolescents (RTSHIA) | Change from baseline at 40 weeks | ||
Secondary | The Risk-Taking and Self-Harm Inventory for adolescents (RTSHIA) | change from baseline at 10 weeks | ||
Secondary | The Risk-Taking and Self-Harm Inventory for adolescents (RTSHIA) | change from baseline at 20 weeks | ||
Secondary | The Risk-Taking and Self-Harm Inventory for adolescents (RTSHIA) | Chage from baseline at 30 weeks | ||
Secondary | ZAN-BPD Zanarini Rating Scale for Borderline Personality Disorder | Change from baseline at 40 weeks | ||
Secondary | The Health of the Nation Outcome Scale for Children and Adolescent (HoNOSCA) | Change from baseline at 40 weeks | ||
Secondary | The Childrens' Global Assessment Scale (CGAS) | Change from baseline at 40 weeks | ||
Secondary | The childhood behaviour checklist (CBCL, Parental outcome measure) | Change from baseline at 40 weeks | ||
Secondary | The childhood behaviour checklist (CBCL, Parental outcome measure) | Change from baseline at 10 weeks | ||
Secondary | The childhood behaviour checklist (CBCL, Parental outcome measure) | Change from baseline at 20 weeks | ||
Secondary | The childhood behaviour checklist (CBCL, Parental outcome measure) | Change from baseline at 30 weeks | ||
Secondary | The borderline personality feature scale for Children - parental version (BPFS-P) | Change from baseline at 40 weeks | ||
Secondary | The borderline personality feature scale for Children - parental version (BPFS-P) | Change from baseline at 10 weeks | ||
Secondary | The borderline personality feature scale for Children - parental version (BPFS-P) | Change from baseline at 20 weeks | ||
Secondary | The borderline personality feature scale for Children - parental version (BPFS-P) | Change from baseline at 30 weeks | ||
Secondary | Number of patients' hospital admissions and visits to the emergency room | Change from baseline at 40 weeks | ||
Secondary | The Youth Self-Report (YSR) | Change from baseline at 10 weeks | ||
Secondary | The Youth Self-Report (YSR) | Change from baseline at 20 weeks | ||
Secondary | The Youth Self-Report (YSR) | Change from baseline at 30 weeks | ||
Secondary | The Youth Self-Report (YSR) | Change from baseline at 40 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT06406972 -
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
|